vascular endothelial growth factor Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (3)

Phase 1 (1)
Unknown (2)

Observational (2)
Interventional (1)

National Cancer Institute, Naples (1)
Shanghai Jiao Tong University School of Medicine (1)
The First Affiliated Hospital of Zhengzhou University (1)

No (3)

No (3)

Adult (18+) (3)

I am/have/had

I am/have/hadEGFR

I am/have/hadmetastatic colorectal cancer

I am/have/hadtumor burden

I am/have/hadvascular endothelial growth factor receptor 2

I am/have/hadcolorectal cancer

I am/have/hadtargeted therapy

I am/have/hadmetastasis

I am/have/hadcancer

I am/have/hadvascular endothelial growth factor

I am/have/hadtumor angiogenesis

I am/have/hadsquamous cell carcinoma

I am/have/hadlymph node metastases

I am/have/hadvegf

I am/have/hadangiogenesis

I am/have/hadtyrosine

I am/have/hadhypoxia

I am/have/hadcarcinoma

I am/have/hadpostoperative complication

I am/have/hadhead and neck squamous cell carcinoma

I am/have/hadimmunosuppression

added new label for I am/have/had

I am looking for

I am looking foroxaliplatin

I am looking forcamrelizumab

I am looking forapatinib

I am looking forvascular endothelial growth factor

I am looking forimmune checkpoint inhibitor

I am looking forgrowth factor

I am looking forfluoropyrimidine

I am looking foraflibercept

I am looking forvegf

I am looking forangiogenesis inhibitors

I am looking forbevacizumab

I am looking fortyrosine

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Dental/Oral Health
Recruiting

Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma

Pre-operative inductive therapy can reduce tumor volume, increase organ retention rate, and reduce distant metastasis rate. Vascular endothelial growth factor (VEGF) receptor in head and neck squamous cell carcinoma is over-expressed and associated with disease invasion and poor prognosis.

camrelizumab

hypoxia

carcinoma

growth factor

tumor burden

0 views
19 Feb, 2024
1 location

For Seniors
For adults
Recruiting in 100s
Observational Study
all
Recruiting

Prediction of Therapeutic Response of Apatinib in Recurrent Gliomas

Apatinib, also known as YN968D1, is a small-molecule tyrosine kinase inhibitor (TKI) that selectively binds to and inhibits vascular endothelial growth factor receptor 2 (VEGFR-2). This study aims to collect clinical, radiological and histopathology imaging including detailed radiological data, survival data, clinical parameters, molecular pathology and images of HE slices …

glioma

vegf

platelet count

apatinib

postoperative complication

0 views
19 Feb, 2024
1 location

For Seniors
For adults
Recruiting in 100s
Observational Study
all
Recruiting

Aflibercept or Bevacizumab as Second-line Treatment of RAS Mutated Metastatic Colorectal Cancer

Furthermore, the serum levels of angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), vascular endothelial growth factor-A and C (VEGF-A and C), stromal cell-derived factor-1 (SDF-1), platelet-derived growth factor beta (PDGF-), basic fibroblast growth factor (bFGF), interleukin-8 (IL-8), chemokine (C-C motif) ligand 2 (CCL2), and chemokine (C-C motif) ligand 5 (CCL5) and Placental Growth …

oxaliplatin

EGFR

vascular endothelial growth factor

metastatic colorectal cancer

growth factor

0 views
19 Feb, 2024
1 location